ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes

Petter Bjornstad¹, Allison Dart², Kim C Donaghue^{3

4}, Axel Dost⁵, Eva L Feldman⁶, Gavin S Tan^{7

8}, R Paul Wadwa¹, Bedowra Zabeen⁹, M Loredana Marcovecchio¹⁰

Affiliations

¹ Section of Endocrinology, Department of Pediatrics, Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
² Department of Pediatrics, Divison of Nephrology, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, Division of Endocrinology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
⁴ Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.
⁵ Department of Pediatrics, Division of Endocrinology, Jena University Hospital, Jena, Germany.
⁶ Department of Medicine, Division of Neurology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
⁷ Singapore Eye Research Institute, Singapore National Eye Center, Singapore.
⁸ Department of Ophthalmology and Visual Sciences, Duke-NUS Medical School, National University of Singapore, Singapore.
⁹ Department of Paediatrics and Changing Diabetes in Children Program, Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders, Dhaka, Bangladesh.
¹⁰ Department of Paediatrics, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Free article

Petter Bjornstad et al. Pediatr Diabetes. 2022 Dec.

Free article

. 2022 Dec;23(8):1432-1450.

doi: 10.1111/pedi.13444.

Petter Bjornstad¹, Allison Dart², Kim C Donaghue^{3

4}, Axel Dost⁵, Eva L Feldman⁶, Gavin S Tan^{7

8}, R Paul Wadwa¹, Bedowra Zabeen⁹, M Loredana Marcovecchio¹⁰

¹ Section of Endocrinology, Department of Pediatrics, Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
² Department of Pediatrics, Divison of Nephrology, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, Division of Endocrinology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
⁴ Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.
⁵ Department of Pediatrics, Division of Endocrinology, Jena University Hospital, Jena, Germany.
⁶ Department of Medicine, Division of Neurology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
⁷ Singapore Eye Research Institute, Singapore National Eye Center, Singapore.
⁸ Department of Ophthalmology and Visual Sciences, Duke-NUS Medical School, National University of Singapore, Singapore.
⁹ Department of Paediatrics and Changing Diabetes in Children Program, Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders, Dhaka, Bangladesh.
¹⁰ Department of Paediatrics, University of Cambridge, and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

No abstract available

References

1. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J Pediatr. 1994;125(2):177-188. doi:10.1016/s0022-3476(94)70190-3
1. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med. 1994;330(1):15-18. doi:10.1056/nejm199401063300103
1. Downie E, Craig ME, Hing S, Cusumano J, Chan AK, Donaghue KC. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care. 2011;34(11):2368-2373. doi:10.2337/dc11-0102
1. Majaliwa ES, Munubhi E, Ramaiya K, et al. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care. 2007;30(9):2187-2192. doi:10.2337/dc07-0594
1. Urbina EM, Isom S, Bell RA, et al. Burden of cardiovascular risk factors over time and arterial stiffness in youth with type 1 diabetes mellitus: the SEARCH for diabetes in youth study. J Am Heart Assoc. 2019;8(13):e010150. doi:10.1161/JAHA.118.010150